Neurofibromatosis type 1 and High-risk Pregnancy: A Case Report

Main Article Content

Orlando Jesus Sarmiento Haydar
Catalina Ivonne Chan Sierra
Juan Carlos Cachón Alpuche
Manuel Andrés Miranda Guillermo

Abstract

Introduction: A high-risk pregnancy is the result of a disease present before pregnancy. Neurofibromatosis type 1 is a rare disease during pregnancy, autosomal dominant, with a mutation in the NF1 gene, on chromosome 17q11.2.


Clinical case: 38-year-old woman, Gestational age 1. Mother with neurofibromatosis type 1. The patient is hypertensive, diagnosed 7 years ago and currently treated with alpha-methyldopa 250 mg every 12 hours orally. She reports the diagnosis of neurofibromatosis type 1 since childhood. Without adequate prenatal control, with alterations in the Doppler ultrasound and complication of intrauterine growth restriction stage 1. A referral is made to third level of care and evaluation by maternal-fetal medicine


Discussion: Pregnancies in patients with neurofibromatosis are predisposed to obstetric complications due to the multisystemic nature of the disease. These patients have a higher incidence of spontaneous abortions, stillbirth, preeclampsia, intrauterine growth restriction (IUGR), oligohydramnios, premature birth and cerebrovascular complications.

Article Details

How to Cite
Sarmiento Haydar, O. J., Catalina Ivonne Chan Sierra, Juan Carlos Cachón Alpuche, & Manuel Andrés Miranda Guillermo. (2024). Neurofibromatosis type 1 and High-risk Pregnancy: A Case Report. International Journal of Medical Science and Clinical Research Studies, 4(12), 2147–2150. https://doi.org/10.47191/ijmscrs/v4-i12-07
Section
Articles

References

I. Hinojoza Remache, R. A., Moreno Carillo, A. B., Valero Ortega , A. E., & Burgos Paladines, A. J. (2024). Neurofibromatosis, Generalidades y Manifestaciones Clínicas Una Revisión Bibliográfica. Ciencia Latina Revista Científica Multidisciplinar, 8(1), 919-928. https://doi.org/10.37811/cl_rcm.v8i1.9465

II. Khare A, K. Verma K, Sambangi A, Dhavala M, B. Tarbox M. Detecting Manifestations of Neurofibromatosis: Cutaneous Diagnostic Criteria for NF1 and NF2. Journal of Clinical Dermatology and Surgery. 2024;2(2). DOI:10.61853/z7cg8k08

III. Daniela, Rosales & Gradis, Olman & María, Enríquez & Shirley, Andino. (2024). Neurofibromatosis tipo 1 en paciente puérpera. Medicina Clínica Práctica. 7.

https://doi.org/10.1016/j.mcpsp.2024.100454.

IV. Dance B, Dardare A, Fleming J, Siow SF, Schlub TE, Crawford H, Saunderson RB, Wong C, Berman Y. The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1. J Dermatol. 2024 Aug;51(8):1050-1059. DOI: 10.1111/1346-8138.17276.

V. Guzmán, Juana & Viteri Rojas, Ana & Vallejo Lopez, Alida. (2023). Embarazo de alto riesgo. RECIAMUC. 7. 371-380. DOI:10.26820/reciamuc/7.(1).enero.2023.371-380.

VI. Arroyo Cadena, L. M., Navas Almeida, A. R., & Hidrobo Guzmán, J. F. (2023). Riesgo obstétrico y su relación con los trastornos hipertensivos en gestantes. Ciencia Latina Revista Científica Multidisciplinar, 7(1), 9707-9720. https://doi.org/10.37811/cl_rcm.v7i1.5168

VII. García Odio, A., Rives González, Y., Reina Arroyo, A., & Álvarez Bolívar, D. (2016). Embarazada con neurofibromatosis tipo 1. Revista de Ciencias Médicas de Pinar del Río, 20(5), 645-650.

VIII. Giliyar S, Kanavi JV, Thomas A. Neurological Disorders Complicating Pregnancy and its Obstetric Outcomes. Int J Infertil Fetal Med 2023;14(2):59–64.

IX. Arroyo Cadena, L. M., Navas Almeida, A. R., & Hidrobo Guzmán, J. F (2023) Riesgo obstétrico y su relación con los trastornos hipertensivos en gestantes. 7(1), 1-16. https://doi.org/10.37811/cl_rcm.v6i5.2903

X. Yahya, Husain; Sani, Hadiza. Eruptive Neurofibromas in Pregnancy. Annals of African Medicine 19(2):p 150-152, Apr–Jun 2020. DOI:10.4103/aam.aam_37_19

XI. Bharathi, Shree & N S, Kubera & Jha, Nivedita & Chanu, Sairem. (2021).. CASE SERIES OF NEUROFIBROMATOSIS AND ITS VARIED MANIFESTATIONS IN PREGNANCY: AN OBSTETRICIAN’S PERSPECTIVE. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, 68–70. https://doi.org/10.36106/ijsr/7824991

XII. Cabezas, Bertha & Canchingre, Karen & Tobar Blandón, Maria & Vaca, Diego & Cabezas, Giovanny & Ochoa Andrade, Miguel. (2021). Restricción del crecimiento intrauterino asociado a factores de riesgo maternos, en el servicio de neonatología del Hospital General IESS-Ibarra. Enero 2016-abril 2018. Revista Ecuatoriana de Medicina EUGENIO ESPEJO.

DOI: 10.23936/ree.v7i13.95

XIII. Sandoval, Isidora, Véliz, Romina, Sepúlveda, Álvaro, Candia, Alejandro A., & Herrera, Emilio A.. (2022). Utilidad de la ecografía Doppler en el diagnóstico, el pronóstico y el manejo de la restricción del crecimiento fetal: situación en Chile. Revista chilena de obstetricia y ginecología, 87(3), 218-228.

https://dx.doi.org/10.24875/rechog.21000011

XIV. Dr. Venus Bansal, Dr. Muskaan Chhabra, Dr. Sonam Gilhotra. Neurofibromatosis and its varied manifestations in pregnancy: A case report. Int J Clin Obstet Gynaecol 2021;5(3):94-98. DOI: 10.33545/gynae.2021.v5.i3b.909